INVESTOR OVERVIEW
Overview
At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART Linker℠ platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.
I R Contact
| IR Contact |
| Andrea Matthews Phone: (617) 349-1971 E-mail: amatthews@catabasis.com |